Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Good Laboratory Practice Requirements for Nonclinical Laboratory Studies
The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and cle...
The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
DATES:
Submit written comments (including recommendations) on the collection of information by December 21, 2026.
ADDRESSES:
To ensure that comments on the information collection are received, OMB recommends that written comments be submitted to
www.reginfo.gov/public/do/PRAMain.
Find this particular information collection by selecting “Currently under Review—Open for Public Comments” or by using the search function. The OMB control number for this information collection is 0910-0119. Also include the FDA docket number found in brackets in the heading of this document.
FOR FURTHER INFORMATION CONTACT:
Kelly Covington, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, 240-402-5661,
PRAStaff@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
In compliance with 44 U.S.C. 3507, FDA has submitted the following proposed
( printed page 74586)
collection of information to OMB for review and clearance.
Good Laboratory Practice Requirements for Nonclinical Laboratory Studies
OMB Control Number 0910-0119—Extension
Sections 409, 505, 512, and 515 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 348, 355, 360b, and 360e) and related statutes require manufacturers of food additives, human drugs and biological products, animal drugs, and medical devices to demonstrate the safety and utility of their product by submitting applications to FDA for research or marketing permits. Such applications contain, among other important items, full reports of all studies done to demonstrate product safety in man and/or other animals. In order to ensure adequate quality control for these studies and to provide an adequate degree of consumer protection, the Agency issued good laboratory practice (GLP) regulations for nonclinical laboratory studies in part 58 (21 CFR part 58). The regulations specify minimum standards for the proper conduct of safety testing and contain sections on facilities, personnel, equipment, standard operating procedures (SOPs), test and control articles, quality assurance, protocol and conduct of a safety study, records and reports, and laboratory disqualification, and include information collection provisions.
Part 58 requires testing facilities engaged in conducting toxicological studies to retain, and make available to regulatory officials, records regarding compliance with GLPs. Records are maintained on file at each testing facility and examined there periodically by FDA inspectors. The GLP regulations require that, for each nonclinical laboratory study, a final report be prepared that documents the results of quality assurance unit inspections, test and control article characterization, testing of mixtures of test and control articles with carriers, and an overall interpretation of nonclinical laboratory studies. The GLP regulations also require written records pertaining to: (1) personnel job descriptions and summaries of training and experience; (2) master schedules, protocols and amendments thereto, inspection reports, and SOPs; (3) equipment inspection, maintenance, calibration, and testing records; (4) documentation of feed and water analyses and animal treatments; (5) test article accountability records; and (6) study documentation and raw data.
Description of Respondents:
Respondents to the collection of information are sponsors of nonclinical laboratory studies that support or are intended to support applications for research or marketing permits for products regulated by FDA.
In the
Federal Register
of April 30, 2026 (91 FR 23273), FDA published a 60-day notice requesting public comment on the proposed collection of information. Two comments were received; however, they did not respond to the questions posed in 5 CFR 1320.8(d).
FDA estimates the burden of this collection of information as follows:
Table 1—Estimated Annual Reporting Burden 1
21 CFR part
Number of
respondents
Number of
responses per
respondent
Total annual responses
Average
burden per
response
Total hours
58.35(b)(7); Quality assurance unit
300
60.25
18,075
1
18,075
58.185; Reporting of nonclinical laboratory study results
300
60.25
18,075
27.65
499,774
Total
517,849
1
There are no capital costs or operating and maintenance costs associated with this collection of information.
Table 2—Estimated Annual Recordkeeping Burden 1
21 CFR Part
Number of recordkeepers
Number of records per recordkeeper
Total annual records
Average burden per recordkeeping
Total hours
58.29(b); Personnel
300
20
6,000
.21 (13 mins.)
1,260
58.35(b)(1)-(6), and (c); Quality assurance unit
300
270.76
81,228
3.36
272,926
58.63(b) and (c); Maintenance and calibration of equipment
300
60
18,000
.09 (5 mins.)
1,620
58.81(a)-(c); SOPs
300
301.80
90,540
.14 (8 mins.)
12,676
58.90(c) and (g); Animal care
300
62.70
18,810
.13 (8 mins.)
2,445
58.105(a) and (b); Test and control article characterization
300
5
1,500
11.8
17,700
58.107(d); Test and control article handling
300
1
300
4.25
1,275
58.113(a); Mixtures of articles with carriers
300
15.33
4,599
6.8
31,273
58.120; Protocol
300
15.38
4,614
32.7
150,878
58.195; Retention of records
300
251.50
75,450
3.9
294,255
Total
786,308
1
There are no capital costs or operating and maintenance costs associated with this collection of information.
( printed page 74587)
Based on an evaluation of the information collection, we are retaining the currently approved estimates. Our assumptions regarding the time needed for the respective activities is based on our experience with the information collection and informal communications with respondents.
Grace R. Graham,
Deputy Commissioner for Policy, Legislation, and International Affairs.
Use this for formal legal and research references to the published document.
91 FR 74585
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Good Laboratory Practice Requirements for Nonclinical Laboratory Studies,” thefederalregister.org (November 19, 2026), https://thefederalregister.org/documents/2026-23541/agency-information-collection-activities-submission-for-office-of-management-and-budget-review-comment-request-good-labo.